» Articles » PMID: 11560288

Oral Contraceptives and Breast Cancer Among African-american Women and White Women

Overview
Publisher Elsevier
Specialty General Medicine
Date 2001 Sep 19
PMID 11560288
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The higher incidence of breast cancer among African-American women younger than 50 as compared to white women points to the need to examine exposures that are common among younger women, including exposure to oral contraceptives (OC). We examined patterns of OC use and their associations with breast cancer in a population-based, case-control study conducted in North Carolina between 1993 and 1996. The study population was comprised of 858 cases and 789 controls, of whom 40% were African-American women. There was little evidence that breast cancer was associated with OC use among older women (age >50) of either race, most of whom discontinued use in the distant past. Among younger women, there was a modest, but nonsignificant, increase in risk associated with ever use of OCs for both African-American and white women. There was a trend of increasing risks with more recent use among African-American women, whereas no such trend was apparent for white women. Overall, we found more substantial age differences than race differences in patterns of OC use and the risk of breast cancer associated with their use. The similarity of the associations between African-American and white women suggest that racial differences in breast cancer incidence are not likely to be attributable to OC use.

Citing Articles

Methylation of ESRα Promoters in Benign Breast Tumors Could Be a Signature for Progression to Breast Cancer in African American Women.

Dasi S, Naab T, Kwabi-Addo B, Apprey V, Beyene D, Dewitty Jr R Cancer Genomics Proteomics. 2025; 22(2):208-230.

PMID: 39993808 PMC: 11880923. DOI: 10.21873/cgp.20497.


Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study.

Williams L, Casbas-Hernandez P, Nichols H, Tse C, Allott E, Carey L PLoS One. 2019; 14(1):e0211488.

PMID: 30682163 PMC: 6347264. DOI: 10.1371/journal.pone.0211488.


Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas.

Williams L, Hoadley K, Nichols H, Geradts J, Perou C, Love M Cancer Causes Control. 2019; 30(1):31-39.

PMID: 30617775 PMC: 6396692. DOI: 10.1007/s10552-018-1121-1.


Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.

Williams L, Nichols H, Hoadley K, Tse C, Geradts J, Bell M Cancer Causes Control. 2017; 29(1):25-32.

PMID: 29124544 PMC: 5903274. DOI: 10.1007/s10552-017-0977-9.


A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium.

Bethea T, Rosenberg L, Hong C, Troester M, Lunetta K, Bandera E Breast Cancer Res. 2015; 17:22.

PMID: 25849024 PMC: 4358874. DOI: 10.1186/s13058-015-0535-x.


References
1.
Mayberry R . Breast cancer risk factors among black women and white women: similarities and differences. Am J Epidemiol. 1992; 136(12):1445-56. DOI: 10.1093/oxfordjournals.aje.a116465. View

2.
Mosher W, Bachrach C . Contraceptive use. United States, 1982. Vital Health Stat 23. 1986; (12):1-52. View

3.
Palmer J, Rosenberg L, Rao R, Strom B, Warshauer M, Harlap S . Oral contraceptive use and breast cancer risk among African-American women. Cancer Causes Control. 1995; 6(4):321-31. DOI: 10.1007/BF00051407. View

4.
Miller D, Rosenberg L, Kaufman D, Stolley P, Warshauer M, Shapiro S . Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol. 1989; 129(2):269-80. DOI: 10.1093/oxfordjournals.aje.a115132. View

5.
Hall I, Newman B, Millikan R, Moorman P . Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol. 2000; 151(8):754-64. DOI: 10.1093/oxfordjournals.aje.a010275. View